Comparison of conventional to intensity modulated radiation therapy for abdominal neuroblastoma

Pediatric Blood and Cancer

Volumn 46, Issue 7, 2006, Pages 739-744

  Paulino, Arnold C ^a,b,c   Ferenci, Michele S ^a   Chiang, Kuang Yueh ^b   Nowlan, Adam W ^a   Marcus Jr , Robert B ^a,b  

^a EMORY CLINIC   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Childhood cancer; Intensity modulated radiation therapy; Kidney; Neuroblastoma; Tolerance dose

Indexed keywords

ABDOMINAL TUMOR; ARTICLE; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; HEALTH CARE COST; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; KIDNEY; NEUROBLASTOMA; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT PLANNING;

ABDOMINAL NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NEUROBLASTOMA; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646579100     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20456     Document Type: Article

References (12)

1. Graham Pole J, Casper J, Elfenbein G, et al. High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: A Pediatric Oncology Group Study. J Clin Oncol 1991;9:152-158.
2. Sibley GS, Mundt AJ, Goldman S, et al. Patterns of failure following total body irradiation and bone marrow transplantation with or without radiotherapy boost for advanced neuroblastoma. Int J Radiat Oncol Biol Phys 1995;32:1127-1135.
3. Kletzel M, Katzenstein HM, Haut PR, et al. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: Results of the Chicago Pilot II study. J Clin Oncol 2002;20:2284-2292.
4. Marcus KJ, Shamberger R, Litman H, et al. Primary tumor control in patients with Stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants. J Pediatr Hematol Oncol 2003;25:934-940.
5. Wolden SL, Gollamudi SV, Kushner BH, et al. Local control with multimodality therapy for Stage 4 neuroblastoma. Int J Radiat Oncol Biol Phys 2000;46:969-974.
6. Haas-Kogan DA, Swift PS, Selch M, et al. Impact of radiotherapy for high-risk neuroblastoma: A Children's Cancer Group study. Int J Radiat Oncol Biol Phys 2003;56:28-39.
7. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-122.
8. Paulino AC, Mayr NA, Simon JH, et al. Locoregional control in infants with neuroblastoma: Role of radiation therapy and late toxicity. Int J Radiat Oncol Biol Phys 2002;52:1025-1031.
9. Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys 2000;46:1239-1246.
10. Paulino AC, Skwarchuk M. Intensity modulated radiation therapy in the treatment of children. Med Dosim 2002;27:115-120.
11. Koshy M, Paulino AC, Marcus RB Jr, et al. Extra-target doses in children receiving multileaf collimator (MLC) based intensity modulated radiation therapy (IMRT). Pediatr Blood Cancer 2004;42:626-630.
12. Hall EJ, Wuu CS. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56:83-88.